Effect of Medicaid Expansion on Rates of Dilated Eye Exams
Ocular Findings and Conjunctival SARS-CoV-2
Facial Trauma Caused by Electric Scooter Accidents
Risk of Progression to Advanced AMD in a U.K. Cohort
Which OCTA Scanning Protocol Is Best for PDR and NPDR?
Elevated Expression of GHRH in Fibrinous Inflammation of PDR
Two-Year AMD Progression Predicts Late AMD and Long-Term Visual Loss
Eye Injuries and Fireworks: Prevalence and Trends
Is Visual Impairment a Risk Factor for Dementia in Women?
Fall-Related Eye Trauma Is on the Rise
Influence of Disc Hemorrhage on Central VF Damage
Explore TEPEZZA® (teprotumumab-trbw) now for your patients with this serious, progressive disease.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22
Public & Patients
Museum of the Eye